To conclude, we suggest sequencing of MAPK1 in patients presenting with Noonan Syndrome phenotype and features of immunodeficiency/immunodysregulation, and careful evaluation of the immune system in patients with activating mutations in MAPK1 and other genes on the Ras-ERK pathway. The gene discussed is MAPK1; the disease is Noonan syndrome.